FDA has issued a warning letter to Zoll Medical Corporation following a 14-month inspection that uncovered significant manufacturing violations affecting critical medical devices including automated external defibrillators, MRI-compatible ventilators, and electrodes
Semaglutide is a GLP-1 receptor agonist the medication class behind FDA-approved brands like Wegovy (chronic weight management) and Ozempic (type 2 diabetes)
It works by reducing appetite, slowing stomach emptying, and improving insulin sensitivity, which can help with weight loss
Moreover, gut microbiota are also altered by bariatric surgery, leading to microbial changes that may contribute to the observed metabolic benefits after surgery (16, 17)
By the end of 2022, tirzepatide had gained substantial market share within the broader GLP-1 receptor agonist class, despite being the newest entrant in this therapeutic category
03 Scarlet Pink